Abstract
Prescription patterns of anti-asthma medications in children vary among doctors in different disciplines and settings, and may reflect differences in treatment outcome. The purpose of this study was to analyze the prescribing patterns of anti-asthma drugs by pediatricians, family physicians and other practitioners. Data for a total of 225,537 anti-asthma prescriptions were collected from the National Health Insurance Research Database for the period from January 1, 2002 to March 31, 2002. These medications included inhaled and oral adrenergics, inhaled and oral corticosteroids, xanthine derivatives, and leukotriene receptor antagonists prescribed by general pediatricians, family physicians and physicians in other disciplines. Oral beta2-agonist was the most commonly prescribed drug used as monotherapy, with prescription rates of 70.4%, 46.9% and 58.0% by pediatricians, family physicians and other physicians, respectively. A xanthine derivative was the next most commonly prescribed monotherapy. Oral corticosteroid combined with oral beta2-agonist, followed by oral beta2-agonist combined with a xanthine derivative were the two most commonly prescribed dual-agent combined therapies by all three physician categories. The prescripti...Continue Reading
References
Aug 1, 1985·The Journal of Allergy and Clinical Immunology·M Weinberger, L Hendeles
Jan 1, 1988·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·K H Hsieh, J J Shen
Sep 9, 1995·BMJ : British Medical Journal·J O Warner
Dec 1, 1994·American Journal of Respiratory and Critical Care Medicine·J P KempA Van As
Jun 1, 1993·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J Bousquet, P Burney
May 1, 1997·Pediatrics·F E SimonsM S Cheang
May 1, 1997·Pediatrics·P A Eggleston
Mar 14, 1998·Pediatrics·P A EgglestonC S Rand
Aug 3, 1999·Pediatrics·D C GoodmanJ Hecht
Oct 26, 1999·Chest·E N GrantK B Weiss
Nov 7, 1999·The Journal of Allergy and Clinical Immunology·P LozanoK B Weiss
May 20, 2000·BMJ : British Medical Journal·S ShrewsburyM Britton
Apr 11, 2001·Drugs·T D HolimonT H Self
May 23, 2001·JAMA : the Journal of the American Medical Association·S C LazarusUNKNOWN Asthma Clinical Research Network for the National Heart, Lung, and Blood Institute
Jan 5, 2002·Pharmacoepidemiology and Drug Safety·C BeimfohrS K Weiland
Mar 20, 2003·Pharmacoepidemiology and Drug Safety·Chi-Yu ChenChun-Yuh Yang
Apr 15, 2004·Allergy·Matthew MasoliUNKNOWN Global Initiative for Asthma (GINA) Program
Citations
Feb 5, 2010·European Journal of Clinical Pharmacology·Antonio ClavennaMaurizio Bonati
May 18, 2010·BMC Pulmonary Medicine·Mike ThomasStephanie Taylor
Aug 9, 2012·Asia Pacific Allergy·Jiu-Yao Wang, Li-Fan Liu
Nov 22, 2013·Asia Pacific Allergy·Jiu-Yao Wang
Mar 14, 2012·Annals of Emergency Medicine·Sanjit K BhogalFrancine M Ducharme
Nov 15, 2011·Current Medical Research and Opinion·Francine M DucharmeLucie Blais
Oct 22, 2011·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Charu GroverBandana Saini
Sep 24, 2008·Pediatric Radiology·Steven M Selbst
Feb 20, 2010·Internal and Emergency Medicine·Carlo Petrini
Jan 1, 2015·Global Pediatric Health·Shota HamadaKoji Kawakami